Reports from the USA, Europe, and Asia demonstrated good efficacy of fenofibrate, an oral medication of the fibrate class (PPARα ligands), in PBC patients with a suboptimal response to UDCA [133,134]. Here, PPARA is linked to primary biliary cholangitis.